-
Most Popular
![Healthcare Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/healthcare-150x150.png)
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks](https://investorplace.com/wp-content/uploads/2024/06/dividend-stocks1600-5-150x150.png)
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
![medicine research, pharmaceutical background, LJPC stock](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-150x150.png)
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
3 Under-$10 Stocks With the Potential to Make You a Millionaire
Buying stocks under $10 might be one of the best ways to breach that million mark. Take a look at these three potential candidates.
Falling Knives: 3 Stocks Getting the Cold Shoulder From Analysts
Uncover key insights on stocks with negative analyst sentiment, including major moves by Alphabet, Nike and ResMed.
3 Biotech Stocks to Sell in July Before They Crash & Burn
While biotech stocks have potential to provide high returns, they are often overly dependent on drug approvals. Sell these before its too late
3 Biotech Stocks Turning DNA Dreams Into Dollars
Investors should consider buying into one of the future avenues of medicine by investing in these three BNA biotech stocks.
3 Highly Rated Biotech Stocks for Your July Buy List
Discover three top-rated biotech stocks that are pushing forward the pharma and biotech revolution on Wall Street.
FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals
Biotech stocks are on the verge of a comeback after a period of underperformance amid a wave of FDA approvals.
3 Undervalued Biotech Gems With 200%+ Analyst Price Targets
These three undervalued biotech stocks have begun garnering investor attention as their treatments show promise.
7 Cannabis Stocks to Sell in July Before They Crash & Burn
With marijuana still facing legalization limbo, it's high time to bail on these seven cannabis stocks to sell.
3 New IPOs to Buy for 20-Bagger Returns by 2030
Hot, high-growth IPO stocks to buy represent promising early-stage companies with visibility for multi-fold growth in revenue.
3 Dividend Compounding Machines Poised for 30%+ Total Returns by 2026
Savvy investors consider three compounder stocks poised to deliver over 30% total returns and ensure steady income streams.
The 3 Best Cannabis Stocks to Buy in July 2024
Stay ahead by investing in these three best cannabis stocks as global legalization expands and U.S. reclassification looms.
3 Top-Rated Gene Editing Stocks Actually Making Money
Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond.
3 Blue-Chip Bargains Trading at Great Depression-Era Valuations
Investors looking for bargain blue-chip stocks should start with these value plays in three important sectors of the economy.
CureVac Layoffs 2024: What to Know About the Latest CVAC Job Cuts
CureVac layoffs are coming for 30% of the vaccine company's employees as it prepares for a restructuring that will save it over 30% in costs.
3 Biotech Moonshots With Imminent Catalyst Potential
Biotech has been one of the most explosive sectors. Better, further upside is likely, thanks to some of the top biotech stocks with catalysts.
7 Safe Haven Stocks to Buy Before the Next Market Correction
Discover resilient safe haven stocks to weather economic fluctuations in restaurants, pharmaceuticals, household products, and retail.
Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns
Psychedelics could be a game-changer in treating mental health issues, creating substantial opportunities for top psychedelic stocks.
3 Penny Stock Moonshots with 300%+ Upside Potential by 2025
If you understand the risks of penny stocks with upside, you may want to investigate these three stocks today.